机构:[1]Sanofi, Gen Med & Emergency Markets, Singapore, Singapore[2]Zhejiang Univ, Sch Med, Affiliated Hosp 2, Hangzhou, Zhejiang, Peoples R China[3]Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Wuhan, Hubei, Peoples R China[4]Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China重点科室诊疗科室神经病学中心神经病学中心首都医科大学附属天坛医院[5]Stroke Ctr, Beijing, Peoples R China[6]Doctor Evidence, Santa Monica, CA USA
第一作者机构:[1]Sanofi, Gen Med & Emergency Markets, Singapore, Singapore
推荐引用方式(GB/T 7714):
Girotra S.,Lou M.,Hu B.,et al.Benefits and risks of clopidogrel versus aspirin monotherapy for acute ischemic stroke - a systematic review and meta-analysis[J].CEREBROVASCULAR DISEASES.2018,45:136-136.
APA:
Girotra, S.,Lou, M.,Hu, B.,Liu, L.,Pack, D.&Sayre, T..(2018).Benefits and risks of clopidogrel versus aspirin monotherapy for acute ischemic stroke - a systematic review and meta-analysis.CEREBROVASCULAR DISEASES,45,
MLA:
Girotra, S.,et al."Benefits and risks of clopidogrel versus aspirin monotherapy for acute ischemic stroke - a systematic review and meta-analysis".CEREBROVASCULAR DISEASES 45.(2018):136-136